These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 19016323

  • 1. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D.
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [Abstract] [Full Text] [Related]

  • 2. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D.
    J Clin Oncol; 2007 Nov 20; 25(33):5194-202. PubMed ID: 17954712
    [Abstract] [Full Text] [Related]

  • 3. Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
    Ignatiadis M, Perraki M, Apostolaki S, Politaki E, Xenidis N, Kafousi M, Stathopoulos E, Lianidou E, Sotiriou C, Georgoulias V, Mavroudis D.
    Clin Breast Cancer; 2007 Dec 20; 7(11):883-9. PubMed ID: 18269779
    [Abstract] [Full Text] [Related]

  • 4. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V.
    Anticancer Res; 2003 Dec 20; 23(2C):1883-90. PubMed ID: 12820473
    [Abstract] [Full Text] [Related]

  • 5. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
    Wülfing P, Borchard J, Buerger H, Heidl S, Zänker KS, Kiesel L, Brandt B.
    Clin Cancer Res; 2006 Mar 15; 12(6):1715-20. PubMed ID: 16551854
    [Abstract] [Full Text] [Related]

  • 6. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
    Xenidis N, Ignatiadis M, Apostolaki S, Perraki M, Kalbakis K, Agelaki S, Stathopoulos EN, Chlouverakis G, Lianidou E, Kakolyris S, Georgoulias V, Mavroudis D.
    J Clin Oncol; 2009 May 01; 27(13):2177-84. PubMed ID: 19332733
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
    Ignatiadis M, Kallergi G, Ntoulia M, Perraki M, Apostolaki S, Kafousi M, Chlouverakis G, Stathopoulos E, Lianidou E, Georgoulias V, Mavroudis D.
    Clin Cancer Res; 2008 May 01; 14(9):2593-600. PubMed ID: 18451221
    [Abstract] [Full Text] [Related]

  • 8. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M, Stathopoulou A, Ignatiadis M, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES.
    Clin Biochem; 2006 Sep 01; 39(9):879-87. PubMed ID: 16925986
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
    Ke F, Wu JM, Yao JE, Bai YJ, Guo AL.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2257-61. PubMed ID: 18001545
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y.
    Breast Cancer Res Treat; 2006 May 28; 97(1):49-55. PubMed ID: 16319978
    [Abstract] [Full Text] [Related]

  • 13. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
    Pestrin M, Bessi S, Galardi F, Truglia M, Biggeri A, Biagioni C, Cappadona S, Biganzoli L, Giannini A, Di Leo A.
    Breast Cancer Res Treat; 2009 Dec 28; 118(3):523-30. PubMed ID: 19597704
    [Abstract] [Full Text] [Related]

  • 14. Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status.
    Souglakos J, Vamvakas L, Apostolaki S, Perraki M, Saridaki Z, Kazakou I, Pallis A, Kouroussis C, Androulakis N, Kalbakis K, Millaki G, Mavroudis D, Georgoulias V.
    Breast Cancer Res; 2006 Dec 28; 8(4):R36. PubMed ID: 16846533
    [Abstract] [Full Text] [Related]

  • 15. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR, Teixeira E, Diamond J, Correia H, Santos S, Neto L, Ribeiro M, Miranda A, Passos-Coelho JL.
    Breast Cancer Res Treat; 2009 Mar 28; 114(2):223-32. PubMed ID: 18409061
    [Abstract] [Full Text] [Related]

  • 16. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P, Salvadori B, Simi L, Bianchi S, Distante V, Cataliotti L, Pazzagli M, Orlando C.
    Hum Pathol; 2006 Jun 28; 37(6):711-8. PubMed ID: 16733212
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.
    Zhao S, Liu Y, Zhang Q, Li H, Zhang M, Ma W, Zhao W, Wang J, Yang M.
    Breast Cancer Res Treat; 2011 Dec 28; 130(3):809-16. PubMed ID: 21311967
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
    Varangot M, Barrios E, Sóñora C, Aizen B, Pressa C, Estrugo R, Lavigna R, Musé I, Osinaga E, Berois N.
    Oncol Rep; 2005 Aug 28; 14(2):537-45. PubMed ID: 16012742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.